| Accession |
PRJCA011691 |
| Title |
Immune-related RNA signature predicts outcome of PD-1 inhibitor combined GEMCIS therapy in advanced intrahepatic cholangiocarcinoma |
| Relevance |
Medical |
| Data types |
Genome sequencing
|
| Organisms |
Homo sapiens
|
| Description |
original data |
| Sample scope |
Monoisolate |
| Release date |
2023-09-05 |
| Publication |
| PubMed ID |
Article title |
Journal name |
DOI |
Year |
| 36159865
|
Immune-related RNA signature predicts outcome of PD-1 inhibitor-combined GEMCIS therapy in advanced intrahepatic cholangiocarcinoma
|
Frontiers in Immunology
|
10.3389/fimmu.2022.943066
|
2022
|
|
|
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| National Natural Science Foundation of China (NSFC)
|
General Program
|
82003161
|
|
|
|
| Submitter |
Tian-mei
Zeng (zengtm@smmu.edu.cn)
|
| Organization |
Eastern Hepatobiliary Surgery Hospital |
| Submission date |
2022-09-05 |
